Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes. (Q37883029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

review article

1 reference

title

Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

0 references

Frank D Waldron-Lynch

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

Kevan C Herold

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

439-452

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd3402

2 February 2020

exact match

0 references

1 reference

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

21 January 2018

1 reference

Continuous glucose monitoring: long live the revolution!

21 January 2018

1 reference

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

Simultaneous pancreas-kidney transplantation in type 1 diabetes

21 January 2018

1 reference

Type 1A diabetes mellitus-associated autoimmunity

21 January 2018

1 reference

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

21 January 2018

1 reference

Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review

21 January 2018

1 reference

Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage

21 January 2018

1 reference

Type 1 diabetes intervention trials 2007: where are we and where are we going?

21 January 2018

1 reference

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future

21 January 2018

1 reference

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

21 January 2018

1 reference

The rise and fall of insulin secretion in type 1 diabetes mellitus

21 January 2018

1 reference

HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families

21 January 2018

1 reference

Genetics of type 1A diabetes

21 January 2018

1 reference

Mechanisms maintaining peripheral tolerance.

21 January 2018

1 reference

The stages of type 1A diabetes: 2005.

21 January 2018

1 reference

Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

21 January 2018

1 reference

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

21 January 2018

1 reference

Novel antigens in type 1 diabetes: the importance of ZnT8.

21 January 2018

1 reference

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

21 January 2018

1 reference

Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset

21 January 2018

1 reference

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

21 January 2018

1 reference

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

21 January 2018

1 reference

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

21 January 2018

1 reference

Type 1 diabetes as a relapsing-remitting disease?

21 January 2018

1 reference

The role of inflammation in insulitis and beta-cell loss in type 1 diabetes

21 January 2018

1 reference

Histopathology of type 1 diabetes: old paradigms and new insights

21 January 2018

1 reference

Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells

21 January 2018

1 reference

Analysis of islet inflammation in human type 1 diabetes.

21 January 2018

1 reference

Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

21 January 2018

1 reference

Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients

21 January 2018

1 reference

Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

Influence of microbial environment on autoimmunity.

21 January 2018

1 reference

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

21 January 2018

1 reference

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice

21 January 2018

1 reference

Thymus-specific deletion of insulin induces autoimmune diabetes

21 January 2018

1 reference

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.

21 January 2018

1 reference

The insulin A-chain epitope recognized by human T cells is posttranslationally modified

21 January 2018

1 reference

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

Prediction of type 1 diabetes in the general population

21 January 2018

1 reference

Autoimmunity since the 1957 clonal selection theory: a little acorn to a large oak.

21 January 2018

1 reference

T cell immunomodulation--the Holy Grail of therapeutic tolerance

21 January 2018

1 reference

How do we define cure of diabetes?

21 January 2018

1 reference

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

21 January 2018

1 reference

Challenges in developing endpoints for type 1 diabetes intervention studies

21 January 2018

1 reference

Treatment of type 1 diabetes mellitus to preserve insulin secretion

21 January 2018

1 reference

Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood

21 January 2018

1 reference

BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with Type 1 diabetes by delaying exposure to gluten.

21 January 2018

1 reference

Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes

21 January 2018

1 reference

Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children

21 January 2018

1 reference

The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design

21 January 2018

1 reference

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes

21 January 2018

1 reference

Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization

21 January 2018

1 reference

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes

21 January 2018

1 reference

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

21 January 2018

1 reference

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes

21 January 2018

1 reference

Antigen-based therapy for the treatment of type 1 diabetes

21 January 2018

1 reference

Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes

21 January 2018

1 reference

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

21 January 2018

1 reference

A novel mechanism for GABA synthesis and packaging into synaptic vesicles

21 January 2018

1 reference

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

21 January 2018

1 reference

Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome

21 January 2018

1 reference

GAD65 as a prototypic autoantigen

21 January 2018

1 reference

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

21 January 2018

1 reference

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

21 January 2018

1 reference

Immune intervention at diagnosis--should we treat children to preserve beta-cell function?

21 January 2018

1 reference

Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus.

21 January 2018

1 reference

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial

21 January 2018

1 reference

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study

21 January 2018

1 reference

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

21 January 2018

1 reference

Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease.

21 January 2018

1 reference

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

21 January 2018

1 reference

Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT).

21 January 2018

1 reference

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

CD3-specific antibodies: a portal to the treatment of autoimmunity

21 January 2018

1 reference

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

21 January 2018

1 reference

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

21 January 2018

1 reference

Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

21 January 2018

1 reference

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.

21 January 2018

1 reference

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

21 January 2018

1 reference

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years

21 January 2018

1 reference

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

21 January 2018

1 reference

Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?

21 January 2018

1 reference

Anti-CD3 mAbs for treatment of type 1 diabetes

21 January 2018

1 reference

The clinical utility of inhibiting CD28-mediated costimulation

21 January 2018

1 reference

CTLA4Ig: bridging the basic immunology with clinical application

21 January 2018

1 reference

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

21 January 2018

1 reference

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

CD28 and CTLA-4 coreceptor expression and signal transduction

21 January 2018

1 reference

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

21 January 2018

1 reference

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

21 January 2018

1 reference

Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment

21 January 2018

1 reference

New immunosuppressive protocols with the advent of novel biological drugs

21 January 2018

1 reference

Rabbit antithymocyte globulin induction therapy in adult renal transplantation

21 January 2018

1 reference

Prevention of transplant rejection: current treatment guidelines and future developments

21 January 2018

1 reference

Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection

21 January 2018

1 reference

Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.

21 January 2018

1 reference

A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset

21 January 2018

1 reference

Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling

21 January 2018

1 reference

Mouse CD20 expression and function

21 January 2018

1 reference

B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.

21 January 2018

1 reference

B cell immunobiology in disease: evolving concepts from the clinic

21 January 2018

1 reference

A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma

21 January 2018

1 reference

B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis

21 January 2018

1 reference

Anti B cell therapy (rituximab) in the treatment of autoimmune diseases

21 January 2018

1 reference

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

21 January 2018

1 reference

Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes

21 January 2018

1 reference

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

21 January 2018

1 reference

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

21 January 2018

1 reference

Immunotherapy of metastatic renal cell carcinoma

21 January 2018

1 reference

The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis

21 January 2018

1 reference

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

21 January 2018

1 reference

What have we learnt from targeted anti-TNF therapy?

21 January 2018

1 reference

Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis

21 January 2018

1 reference

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

21 January 2018

1 reference

Blockade of interleukin 1 in type 1 diabetes mellitus

21 January 2018

1 reference

Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes

21 January 2018

1 reference

The anti-interleukin-1 in type 1 diabetes action trial--background and rationale

21 January 2018

1 reference

Remodeling rodent models to mimic human type 1 diabetes

21 January 2018

1 reference

A model for harmonizing flow cytometry in clinical trials

21 January 2018

1 reference

Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice

21 January 2018

1 reference

Humanized mice in translational biomedical research

21 January 2018

1 reference

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

Safety of biologics, lessons learnt from TGN1412

21 January 2018

1 reference

Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs

21 January 2018

1 reference

A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?

21 January 2018

1 reference

Innate immunity and its role in type 1 diabetes

21 January 2018

1 reference

Innate and adaptive autoimmunity in type 1 diabetes

21 January 2018

1 reference

An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.

21 January 2018

1 reference

Immunoregulatory pathways controlling progression of autoimmunity in NOD mice

21 January 2018

1 reference

The road not taken: a path to curing type 1 diabetes?

21 January 2018

1 reference

Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside

21 January 2018

1 reference

How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model

21 January 2018

1 reference

How viral infections affect the autoimmune process leading to type 1 diabetes

21 January 2018

1 reference

Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model

21 January 2018

1 reference

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope

21 January 2018

1 reference

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood

31 March 2020

1 reference

Levees of immunological tolerance

31 March 2020

1 reference

Concordance for islet autoimmunity among monozygotic twins

31 March 2020

1 reference

Prevention of type 1 diabetes: the time has come.

31 March 2020

1 reference

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies

31 March 2020

1 reference

Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States

31 March 2020

1 reference

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

31 March 2020

1 reference

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

31 March 2020

1 reference

Pathologic anatomy of the pancreas in juvenile diabetes mellitus

31 March 2020

1 reference

Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients

31 March 2020

1 reference

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice

31 March 2020

1 reference

Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group

31 March 2020

1 reference

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial

31 March 2020

1 reference

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

31 March 2020

1 reference

Active suppression of diabetes after oral administration of insulin is determined by antigen dosage

31 March 2020

1 reference

Rational development of antigen-specific therapies for type 1 diabetes

31 March 2020

2 references

31 March 2020

12 December 2020

Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients

1 reference

Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials

31 March 2020

1 reference

Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus

31 March 2020

1 reference

Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin

31 March 2020

1 reference

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study

31 March 2020

1 reference

PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1

31 March 2020

1 reference

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

31 March 2020

1 reference

Regulatory T cells and type 1 diabetes

31 March 2020

1 reference

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients

31 March 2020

1 reference

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes

31 March 2020

1 reference

Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate

31 March 2020

1 reference

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model

31 March 2020

1 reference

Development of type 1 diabetes despite severe hereditary B-cell deficiency

31 March 2020

1 reference

Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice

31 March 2020

1 reference

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

31 March 2020

1 reference

NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse

31 March 2020

1 reference

Following a diabetogenic T cell from genesis through pathogenesis

31 March 2020

1 reference

Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis

31 March 2020

1 reference

Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled

31 March 2020

1 reference

IL-1 receptor deficiency slows progression to diabetes in the NOD mouse

31 March 2020

1 reference

Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor

31 March 2020

1 reference

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

31 March 2020

1 reference

Human CD3 Transgenic Mice: Preclinical Testing of Antibodies Promoting Immune Tolerance

31 March 2020

1 reference

Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice

31 March 2020

1 reference

Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation

31 March 2020

1 reference

12 December 2020

Genetic and immunological basis of autoimmune diabetes in the NOD mouse

1 reference

12 December 2020

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.

1 reference

12 December 2020

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

12 December 2020

Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Treatment of metastatic melanoma: an overview

1 reference

12 December 2020

Antiislet autoantibodies usually develop sequentially rather than simultaneously

1 reference

12 December 2020

CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice

1 reference

12 December 2020

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody

1 reference

12 December 2020

CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin

1 reference

12 December 2020

A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo

1 reference

12 December 2020

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass

1 reference

12 December 2020

Role of IL-1beta in type 2 diabetes

1 reference

12 December 2020

Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells

1 reference

12 December 2020

Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD3402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629294%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference